A trispecific T cell engager has been developed to redirect bystander T cells, overcoming immunosuppression and enhancing antitumour immunity across multiple solid tumour types, alongside a machine learning-based tool to predict its efficacy.
- Changrui Yang
- Shanni Guo
- Fan Yang
